These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 21818135)

  • 1. Selective modification of HK peptides enhances siRNA silencing of tumor targets in vivo.
    Chou ST; Leng Q; Scaria P; Woodle M; Mixson AJ
    Cancer Gene Ther; 2011 Oct; 18(10):707-16. PubMed ID: 21818135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface-modified HK:siRNA nanoplexes with enhanced pharmacokinetics and tumor growth inhibition.
    Chou ST; Leng Q; Scaria P; Kahn JD; Tricoli LJ; Woodle M; Mixson AJ
    Biomacromolecules; 2013 Mar; 14(3):752-60. PubMed ID: 23360232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic delivery of HK Raf-1 siRNA polyplexes inhibits MDA-MB-435 xenografts.
    Leng Q; Scaria P; Lu P; Woodle MC; Mixson AJ
    Cancer Gene Ther; 2008 Aug; 15(8):485-95. PubMed ID: 18483501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buffering capacity and size of siRNA polyplexes influence cytokine levels.
    Leng Q; Chou ST; Scaria PV; Woodle MC; Mixson AJ
    Mol Ther; 2012 Dec; 20(12):2282-90. PubMed ID: 23032972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly branched HK peptides are effective carriers of siRNA.
    Leng Q; Scaria P; Zhu J; Ambulos N; Campbell P; Mixson AJ
    J Gene Med; 2005 Jul; 7(7):977-86. PubMed ID: 15772938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histidine-lysine peptides as carriers of nucleic acids.
    Leng Q; Goldgeier L; Zhu J; Cambell P; Ambulos N; Mixson AJ
    Drug News Perspect; 2007 Mar; 20(2):77-86. PubMed ID: 17440630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neuropilin-1 receptor mediates enhanced tumor delivery of H2K polyplexes.
    Leng Q; Mixson AJ
    J Gene Med; 2016 Jul; 18(7):134-44. PubMed ID: 27257039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel dendritic nanocarrier of polyamidoamine-polyethylene glycol-cyclic RGD for "smart" small interfering RNA delivery and in vitro antitumor effects by human ether-à-go-go-related gene silencing in anaplastic thyroid carcinoma cells.
    Li G; Hu Z; Yin H; Zhang Y; Huang X; Wang S; Li W
    Int J Nanomedicine; 2013; 8():1293-306. PubMed ID: 23569377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RGD-based active targeting of novel polycation liposomes bearing siRNA for cancer treatment.
    Yonenaga N; Kenjo E; Asai T; Tsuruta A; Shimizu K; Dewa T; Nango M; Oku N
    J Control Release; 2012 Jun; 160(2):177-81. PubMed ID: 22019557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of disulfide-bridge on the activities of H-shape gemini-like cationic lipid based siRNA delivery.
    Ma XF; Sun J; Qiu C; Wu YF; Zheng Y; Yu MZ; Pei XW; Wei L; Niu YJ; Pang WH; Yang ZJ; Wang JC; Zhang Q
    J Control Release; 2016 Aug; 235():99-111. PubMed ID: 27242198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual antitumoral potency of EG5 siRNA nanoplexes armed with cytotoxic bifunctional glutamyl-methotrexate targeting ligand.
    Lee DJ; Kessel E; Edinger D; He D; Klein PM; Voith von Voithenberg L; Lamb DC; Lächelt U; Lehto T; Wagner E
    Biomaterials; 2016 Jan; 77():98-110. PubMed ID: 26584350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted systemic delivery of siRNA to cervical cancer model using cyclic RGD-installed unimer polyion complex-assembled gold nanoparticles.
    Yi Y; Kim HJ; Mi P; Zheng M; Takemoto H; Toh K; Kim BS; Hayashi K; Naito M; Matsumoto Y; Miyata K; Kataoka K
    J Control Release; 2016 Dec; 244(Pt B):247-256. PubMed ID: 27590214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Modular PEG Incorporation Strategies for Stabilization of Peptide-siRNA Nanocomplexes.
    Lo JH; Kwon EJ; Zhang AQ; Singhal P; Bhatia SN
    Bioconjug Chem; 2016 Oct; 27(10):2323-2331. PubMed ID: 27583545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced silencing and stabilization of siRNA polyplexes by histidine-mediated hydrogen bonds.
    Chou ST; Hom K; Zhang D; Leng Q; Tricoli LJ; Hustedt JM; Lee A; Shapiro MJ; Seog J; Kahn JD; Mixson AJ
    Biomaterials; 2014 Jan; 35(2):846-55. PubMed ID: 24161165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A tumor-targeting cRGD-EGFR siRNA conjugate and its anti-tumor effect on glioblastoma in vitro and in vivo.
    He S; Cen B; Liao L; Wang Z; Qin Y; Wu Z; Liao W; Zhang Z; Ji A
    Drug Deliv; 2017 Nov; 24(1):471-481. PubMed ID: 28181832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An RGD-modified MRI-visible polymeric vector for targeted siRNA delivery to hepatocellular carcinoma in nude mice.
    Wu C; Gong F; Pang P; Shen M; Zhu K; Cheng D; Liu Z; Shan H
    PLoS One; 2013; 8(6):e66416. PubMed ID: 23922634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEG-detachable cationic polyaspartamide derivatives bearing stearoyl moieties for systemic siRNA delivery toward subcutaneous BxPC3 pancreatic tumor.
    Kim HJ; Oba M; Pittella F; Nomoto T; Cabral H; Matsumoto Y; Miyata K; Nishiyama N; Kataoka K
    J Drug Target; 2012 Jan; 20(1):33-42. PubMed ID: 22066783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging chemically modified adenovirus for targeting tumors expressing integrin alphavbeta3 in living mice with mutant herpes simplex virus type 1 thymidine kinase PET reporter gene.
    Xiong Z; Cheng Z; Zhang X; Patel M; Wu JC; Gambhir SS; Chen X
    J Nucl Med; 2006 Jan; 47(1):130-9. PubMed ID: 16391197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron-Oxide-Based Nanovector for Tumor Targeted siRNA Delivery in an Orthotopic Hepatocellular Carcinoma Xenograft Mouse Model.
    Wang K; Kievit FM; Sham JG; Jeon M; Stephen ZR; Bakthavatsalam A; Park JO; Zhang M
    Small; 2016 Jan; 12(4):477-87. PubMed ID: 26641029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.